Quanterix is looking to expand his European commercial operation team with a results-driven team player to represent its ultrasensitive biomarker platform (instrumentation, consumables, and services) for the life science research market. This role will be responsible for the Northern part of DACH region concentrating on research-use-only segments (pharma/biopharma, academia, government, and CROs). The ideal candidate will come with experience and established relationships in the target markets. He or she will be responsible for nurturing existing opportunities, building the pipeline, and executing on it. This role requires familiarity with current immunoassay platforms and must be able to convincingly articulate the benefits of the Simoa technology. This role will initially involve a strong component of team-based market/business development and technology evangelization. The unique and revolutionary value proposition of the Simoa franchise requires the person responsible for this role to be very comfortable prospecting new customers and successfully pitching the potential impact of the Quanterix solution to create initial interest. Close collaboration with marketing, applications, and all internal departments expected.
- Minimum of Ms or Ph.D. from accredited institution with major in biology, chemistry, or related fields;
- 5+ years sales experience in life science research tools and/or analytical instrumentation;
- Strong sales track record;
- Experience selling immunoassay instrumentation & consumables strongly preferred;
- Experience selling novel, ground-breaking technologies preferable;
- Conviction in the promise and value of Simoa;
- Team spirit, positive attitude, strong work ethic, and sense of humor required.
- Based in the North of Germany; and,
- Ability to travel up to 40-50% of the time.
Founded in 2007 and located in Billerica , MA, Quanterix has developed an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays.. The Simoa™ technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. Quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at Tufts University by Dr. David Walt, scientific founder of Quanterix and Illumina.
Quanterix offers a dynamic, fast-paced, entrepreneurial environment. The company launched its first Simoa Analyzer to the life science research market in mid-2013, and is growing rapidly with HD-X, SR-X and SP-X Analyzers to meet an extremely high degree of customer interest and demand. Quanterix offers a competitive benefits package and is an equal opportunity employer.